To decrease the impact of #COVID19, related hospitalisations and mortality, countries should plan for a continued roll-out of vaccines in 2023.

In line with @ECDC_EU guidance, efforts should focus on protecting older adults and other vulnerable groups.

#UnitedInProtection
RT @EMA_News: #COVID19vaccines: Where do we stand?

✅ 8 authorisations completed
✅ 4 #AdaptedVaccines approved
✅ 5 virus strains targeted – Wuhan, Alpha, Beta, Omicron BA.1, Omicron BA. 4-5
✅ 1…

🐦🔗: https://n.respublicae.eu/EU_Health/status/1645697035218169857

#COVID19vaccines: Where do we stand?

✅ 8 authorisations completed
✅ 4 #AdaptedVaccines approved
✅ 5 virus strains targeted – Wuhan, Alpha, Beta, Omicron BA.1, Omicron BA. 4-5
✅ 1 marketing authorisation application under review

#VaccinesWork #UnitedinProtection

🐦🔗: https://n.respublicae.eu/EMA_News/status/1643932058992144385

#COVID19vaccines: Where do we stand?

✅ 7 authorisations completed
✅ 4 #AdaptedVaccines approved
✅ 4 virus strains targeted – Wuhan, Beta, Omicron BA.1, Omicron BA. 4-5
✅ 2 marketing authorisation applications under review

#VaccinesWork #UnitedinProtection

🐦🔗: https://n.respublicae.eu/EMA_News/status/1638812833461977089

RT @EMA_News: #COVID19vaccines: Where do we stand?

✅ 7 authorisations completed
✅ 4 #AdaptedVaccines approved
✅ 4 virus strains targeted – Wuhan, Beta, Omicron BA.1, Omicron BA. 4-5
✅ 2 marketing authorisation applications under review

#VaccinesWork #UnitedinProtection

🐦🔗: https://n.respublicae.eu/EU_Health/status/1638815782141411328

#COVID19vaccines: Where do we stand?

✅ 7 authorisations completed
✅ 4 #AdaptedVaccines approved
✅ 4 virus strains targeted – Wuhan, Beta, Omicron BA.1, Omicron BA. 4-5

#VaccinesWork #UnitedinProtection

🐦🔗: https://n.respublicae.eu/EMA_News/status/1606201703145127936

The data suggest that primary vaccination with #AdaptedVaccines should give rise to a broad immune response in people who have not yet been exposed to, or vaccinated against, #COVID19.

#EMAPresser ⬇️
?s=20&t=KqADz96VvID1BBfuQsfSMw
RT @EMA_News: EMA concludes that adapted mRNA #COVID19vaccines targeting the original strain and Omicron BA.4-5 subvariants of the SARS-CoV-2 virus may be used for initial vaccination.

These #AdaptedVaccines are currently only authoris…

🐦🔗: https://n.respublicae.eu/EMA_News/status/1603692963514777601

At the end of 2022, we have:
🔶7 #COVID19vaccines
🔶4 #AdaptedVaccines that target several variants of the virus
🔶vaccines for children from 6 months of age, particularly those with underlying conditions

#EMAPresser

🐦🔗: https://n.respublicae.eu/EMA_News/status/1603692024573607939

RT @EMA_News: The data suggest that primary vaccination with #AdaptedVaccines should give rise to a broad immune response in people who have not yet been exposed to, or vaccinated against, #COVID19.

#EMAPresser ⬇️
?s=20&t=KqADz96VvID1BBfuQsfSMw

🐦🔗: https://n.respublicae.eu/EU_Health/status/1603693428117757952

RT @EMA_News: At the end of 2022, we have:
🔶7 #COVID19vaccines
🔶4 #AdaptedVaccines that target several variants of the virus
🔶vaccines for children from 6 months of age, particularly those with underlying conditions

#EMAPresser

🐦🔗: https://n.respublicae.eu/EU_Health/status/1603692609163218945

EMA concludes that adapted mRNA #COVID19vaccines targeting the original strain and Omicron BA.4-5 subvariants of the SARS-CoV-2 virus may be used for initial vaccination.

These #AdaptedVaccines are currently only authorised as boosters.

Find out more ⬇️ https://www.ema.europa.eu/en/news/etf-concludes-bivalent-original-omicron-ba4-5-mrna-vaccines-may-be-used-primary-vaccination

🐦🔗: https://n.respublicae.eu/EMA_News/status/1600163966281547783

Adapted vaccines target different variants for an optimal protection as the virus evolves.

@EMA_News has now concluded that bivalent original/Omicron BA.4-5 mRNA vaccines may be used for primary vaccination.

#UnitedInProtection
RT @EMA_News: EMA concludes that adapted mRNA #COVID19vaccines targeting the original strain and Omicron BA.4-5 subvariants of the SARS-CoV-2 virus may be used for initial vaccination.

These #AdaptedVaccines are currently only authorised…

🐦🔗: https://n.respublicae.eu/EU_Health/status/1600167441862053898

#COVID19vaccines: Where are we now?

✅ 7 authorisations completed
✅ 4 #AdaptedVaccines approved
✅ 4 virus strains targeted– Wuhan, Beta, Omicron BA.1, Omicron BA. 4-5

#VaccinesWork #SafeVaccines

🐦🔗: https://nitter.eu/EMA_News/status/1592535713073205249

RT @EMA_News: #COVID19vaccines: Where are we now?

✅ 7 authorisations completed
✅ 4 #AdaptedVaccines approved
✅ 4 virus strains targeted– Wuhan, Beta, Omicron BA.1, Omicron BA. 4-5

#VaccinesWork #SafeVaccines

🐦🔗: https://nitter.eu/ECDC_EU/status/1592536866544394240

RT @EMA_News: #COVID19vaccines: Where are we now?

✅ 7 authorisations completed
✅ 4 #AdaptedVaccines approved
✅ 4 virus strains targeted– Wuhan, Beta, Omicron BA.1, Omicron BA. 4-5

#VaccinesWork #SafeVaccines

🐦🔗: https://nitter.eu/EU_Health/status/1592536448234049536

RT @EMA_News: #COVID19vaccines: Where are we now?

✅ 6 authorisations completed
✅ 4 #AdaptedVaccines targeting Omicron subvariants approved

#VaccinesWork #SafeVaccines

🐦🔗: https://nitter.eu/Food_EU/status/1583391199125463040

‼️ EMA has started evaluating an application for the authorisation of an adapted version of Spikevax targeting the original virus that causes #COVID19 and its #Omicron subvariants BA.4/5

#AdaptedVaccines #COVID19vaccines

🐦🔗: https://nitter.eu/EMA_News/status/1574723403025592321

#AdaptedVaccines present our immune system with different strains of the virus to expand the immune response towards strains that have circulated recently. #EMAPresser #COVID19

🐦🔗: https://nitter.eu/EMA_News/status/1572217116408926209

RT @EMA_News: #COVID19vaccines: Where are we now?

6⃣ authorisations completed
3⃣ #AdaptedVaccines targeting Omicron subvariants approved

#Covid19 #VaccinesWork 💉

🐦🔗: https://nitter.eu/ECDC_EU/status/1570444672492863489

RT @EMA_News: #COVID19vaccines: Where are we now?

6⃣ authorisations completed
3⃣ #AdaptedVaccines targeting Omicron subvariants approved

#Covid19 #VaccinesWork 💉

🐦🔗: https://nitter.eu/zofijamazej/status/1570490220776390657

#COVID19vaccines: Where are we now?

6⃣ authorisations completed
3⃣ #AdaptedVaccines targeting Omicron subvariants approved

#Covid19 #VaccinesWork 💉

🐦🔗: https://nitter.eu/EMA_News/status/1570384397052022784